Stay informed with the latest litigation news. Explore now

IP Verse

Dosage Form Containing Oxycodone And Naloxone - EP3578173B1

EP3578173

EURO CELTIQUE
Application Number
EP19167974A
Filing Date
Feb 28, 2006
Status
Granted And Under Opposition
Sep 23, 2022
Grant Date
Oct 26, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2568967B2
EP2706982B2
EP3024461B1

Bibliography

The patent EP3578173B1 was granted to Euro Celtique on Oct 26, 2022 following the initial filing on Feb 28, 2006 under the application number EP19167974A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ETHYPHARMJul 26, 2023ADMISSIBLE
JP PEELJul 26, 2023ADMISSIBLE
PUREN PHARMAJul 26, 2023ADMISSIBLE
DEVELCO PHARMA SCHWEIZOct 26, 2022ADMISSIBLE
SANDOZOct 26, 2022WITHDRAWN

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents